Category: RNA Diagnostics

FURTHER EVIDENCE RDA™ MAY PREDICT CLINICAL OUTCOME OF CHEMOTHERAPY IN JOURNAL OF THE NATIONAL CANCER INSTITUTE

A new study provides further evidence that the Rna Disruption Assay™ (RDA™) may be a useful tool to predict the clinical outcome of neoadjuvant chemotherapy in breast cancer patients. RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer (Toomey et al), conducted under the direction …

Continue reading

FURTHER EVIDENCE RDA™ MAY PREDICT CLINICAL OUTCOME OF CHEMOTHERAPY IN JOURNAL OF THE NATIONAL CANCER INSTITUTE

A new study provides further evidence that the Rna Disruption Assay™ (RDA™) may be a useful tool to predict the clinical outcome of neoadjuvant chemotherapy in breast cancer patients. RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer (Toomey et al), conducted under the direction …

Continue reading

RNA DISRUPTION IS ASSOCIATED WITH RESPONSE TO MULTIPLE CLASSES OF CHEMOTHERAPY DRUGS IN TUMOR CELL LINES

Results demonstrate that RNA disruption is induced by multiple chemotherapy agents in cell lines from different tissues and is associated with drug response. MORE>>

RNA DIAGNOSTICS NEWS – APRIL 2016 – INTERVIEW WITH JEREMY BRIDGE-COOK, PRESIDENT & CEO

APRIL 2016 – This month’s version of RNA Diagnostics News features an interview with new President & CEO Jeremy Bridge-Cook.  Find the interview and full newsletter here.  MORE>>

RNA DIAGNOSTICS INC. APPOINTS DR. JEREMY BRIDGE-COOK PRESIDENT AND CEO

Dr. Ken Pritzker, on behalf of the Board of Directors of Rna Diagnostics Inc., is pleased to announce the appointment of Dr. Jeremy Bridge-Cook to the position of President and Chief Executive Officer of Rna Diagnostics Inc. Dr. Bridge-Cook is a highly accomplished In Vitro Diagnostics (IVD) executive with  comprehensive experience developing and launching innovative …

Continue reading